Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone

References

• Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol 2002;57A:M76–M99.
   Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003;149:601–608.
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen T-P, Valkonen V-P, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036–1041.
   PubMed Web of Science ®Google Scholar
• Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetics. J Clin Endocrinol Metab 2004;89:5462–5468.
   PubMed Web of Science ®Google Scholar
• Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson K-F, Tripathy D, Yialamas M, Groop L, Elahi D, et al Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005;28:1636–1642.
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen T-P, Valkonen V-P, Salonen JT. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005;90:712–719.
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Meehan AG, Shah A. The age-related decline in testosterone is significantly exacerbated in obese men with the metabolic syndrome – what are the implications of this for the relatively high incidence of erectile dysfunction observed in these men? J Urol 2006;176:1524–1528.
   PubMed Web of Science ®Google Scholar
• Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H, Dandona P. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 2006;29:2289–2294.
   PubMed Web of Science ®Google Scholar
• Giltay EJ, Haider A, Saad F, Gooren LJ. C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation. Andrologia 2008;40:398–400.
   PubMed Web of Science ®Google Scholar
• Haider A, Gooren LJ, Padungtod P, Saad F. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia 2009;41:7–13.
   PubMed Web of Science ®Google Scholar
• Ariyo AA, Thach C, Tracy R. Cardiovascular Health Study Investigators. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003;349:2108–2115.
   PubMed Web of Science ®Google Scholar
• Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 2000;102:1082–1085.
   PubMed Web of Science ®Google Scholar
• Kamstrup PR, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008;117:176–184.
   PubMed Web of Science ®Google Scholar
• Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez WJL, Stampfer MS, Marcovina SM. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the Physicians' Health Study. Clin Chem 2004;50:1364–1371.
   PubMed Web of Science ®Google Scholar
• Kamstrup PR, Tybjærg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331–2339.
   PubMed Web of Science ®Google Scholar
• Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp(a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 1992;89:1166–1171.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Wallace EM, Wu FCW. Effect of testosterone enanthate on serum lipoproteins in man. Contraception 1995;52:115–119.
   PubMed Web of Science ®Google Scholar
• Zmuda JM, Thompson PD, Dickenson R, Bausserman LL. Testosterone decreases lipoprotein(a) in men. Am J Cardiol 1996;77:1244–1247.
   PubMed Web of Science ®Google Scholar
• Marcovina SM, Lippi G, Bagatell CJ, Bremner WJ. Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level. Atherosclerosis 1996;122:89–95.
   PubMed Web of Science ®Google Scholar
• Metropolitan Life Insurance Company: 1983 metropolitan height and weight tables. Stat Bull 1983;64:2–9.
   Google Scholar
• Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Bozbas H, Yildirir A, Pirat B, Eroglu S, Korkmaz ME, Atar I, Ulus T, Aydinalp A, Oezin B, Muederrisoglu H. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis? Anatol J Cardiol 2008;8:111–115.
   Google Scholar
• Mohan V, Rema M, Deepa R, Sastry NG, Haranath SP, Enas EA, Premalatha G. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 1998;21:1819–1823.
   Google Scholar
• Eagon PK, Elm MS, Stafford EA, Porter LE. Androgen receptor in human liver: characterization and quantitation in normal and diseased liver. Hepatology 1994;19:92–100.
   Google Scholar